Print version of this report
Type of Product Medical Device
TGA Recall Reference RC-2015-RN-00964-1
Product Name/Description EnVision Flex/HRP visualisation reagent, part of EnVision Flex/Flex+ Kits
(For invitro diagnostics use. Intended for use in immunohistochemistry)

Multiple products affected
Product Codes: K8000, K8002, K8023, K8010, K8012, K8024 and GV800
Multiple Lot Numbers affected

ARTG Number: 199416
Recall Action Level Hospital
Recall Action Classification Class II
Recall Action Commencement Date 12/10/2015
Responsible Entity Dako Australia Pty Ltd
Reason/Issue Dako has determined that there is a defect in one lot of a buffer used in the manufacturing of some corresponding lots of the EnVision FLEX/HRP visualisation reagent. Specifically, some instances of moderate-to-strong non-specific staining and overly-strong specific staining have been observed when this visualisation reagent was used with four antibodies against the biomarkers Epstein-Barr Virus (EBV), MUM-1, Wilms’ Tumor1(WT1) Protein and Smooth Muscle Actin (SMA). Negative control antibodies in the same run were negative, and did not show the non-specific staining.
Recall Action Recall
Recall Action Instructions Dako is advising users to destroy any remaining lots of affected units.
Dako is recommending that users re-evaluate test results from affected lots. This action has been closed-out on 25/08/2016.
Contact Information 02 9922 0700 - Dako